vs

Side-by-side financial comparison of Excelerate Energy, Inc. (EE) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

Excelerate Energy, Inc. is the larger business by last-quarter revenue ($317.6M vs $197.9M, roughly 1.6× REPLIGEN CORP). On growth, Excelerate Energy, Inc. posted the faster year-over-year revenue change (15.7% vs 13.6%). Over the past eight quarters, Excelerate Energy, Inc.'s revenue compounded faster (26.0% CAGR vs 14.4%).

Excelerate Energy, Inc. is a global leading provider of flexible liquefied natural gas (LNG) solutions, offering floating storage and regasification units, LNG delivery services and integrated infrastructure projects. It serves utility and industrial clients across Europe, Asia, Latin America and the Middle East, supporting markets to achieve accessible low-carbon energy transitions.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

EE vs RGEN — Head-to-Head

Bigger by revenue
EE
EE
1.6× larger
EE
$317.6M
$197.9M
RGEN
Growing faster (revenue YoY)
EE
EE
+2.0% gap
EE
15.7%
13.6%
RGEN
Faster 2-yr revenue CAGR
EE
EE
Annualised
EE
26.0%
14.4%
RGEN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EE
EE
RGEN
RGEN
Revenue
$317.6M
$197.9M
Net Profit
$13.3M
Gross Margin
52.5%
Operating Margin
22.2%
9.0%
Net Margin
6.7%
Revenue YoY
15.7%
13.6%
Net Profit YoY
143.9%
EPS (diluted)
$0.24
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EE
EE
RGEN
RGEN
Q4 25
$317.6M
$197.9M
Q3 25
$391.0M
$188.8M
Q2 25
$204.6M
$182.4M
Q1 25
$315.1M
$169.2M
Q4 24
$274.6M
$174.1M
Q3 24
$193.4M
$154.9M
Q2 24
$183.3M
$154.1M
Q1 24
$200.1M
$151.3M
Net Profit
EE
EE
RGEN
RGEN
Q4 25
$13.3M
Q3 25
$14.9M
Q2 25
$14.9M
Q1 25
$5.8M
Q4 24
$-30.3M
Q3 24
$-654.0K
Q2 24
$3.3M
Q1 24
$2.1M
Gross Margin
EE
EE
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
EE
EE
RGEN
RGEN
Q4 25
22.2%
9.0%
Q3 25
22.3%
8.9%
Q2 25
21.2%
7.6%
Q1 25
20.9%
3.9%
Q4 24
21.9%
-17.7%
Q3 24
30.9%
-5.1%
Q2 24
27.2%
1.0%
Q1 24
22.6%
1.3%
Net Margin
EE
EE
RGEN
RGEN
Q4 25
6.7%
Q3 25
7.9%
Q2 25
8.2%
Q1 25
3.4%
Q4 24
-17.4%
Q3 24
-0.4%
Q2 24
2.2%
Q1 24
1.4%
EPS (diluted)
EE
EE
RGEN
RGEN
Q4 25
$0.24
$0.24
Q3 25
$0.43
$0.26
Q2 25
$0.15
$0.26
Q1 25
$0.46
$0.10
Q4 24
$0.42
$-0.55
Q3 24
$0.35
$-0.01
Q2 24
$0.26
$0.06
Q1 24
$0.24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EE
EE
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$538.2M
$767.6M
Total DebtLower is stronger
$936.3M
$542.2M
Stockholders' EquityBook value
$2.2B
$2.1B
Total Assets
$4.1B
$2.9B
Debt / EquityLower = less leverage
0.42×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EE
EE
RGEN
RGEN
Q4 25
$538.2M
$767.6M
Q3 25
$462.6M
$748.7M
Q2 25
$426.0M
$708.9M
Q1 25
$619.5M
$697.2M
Q4 24
$537.5M
$757.4M
Q3 24
$608.4M
$784.0M
Q2 24
$609.1M
$809.1M
Q1 24
$578.9M
$780.6M
Total Debt
EE
EE
RGEN
RGEN
Q4 25
$936.3M
$542.2M
Q3 25
$942.0M
$537.9M
Q2 25
$946.2M
Q1 25
$322.6M
Q4 24
$333.6M
$525.6M
Q3 24
$345.7M
Q2 24
$356.4M
Q1 24
$366.9M
Stockholders' Equity
EE
EE
RGEN
RGEN
Q4 25
$2.2B
$2.1B
Q3 25
$2.2B
$2.1B
Q2 25
$2.1B
$2.1B
Q1 25
$1.9B
$2.0B
Q4 24
$1.9B
$2.0B
Q3 24
$1.9B
$2.0B
Q2 24
$1.8B
$2.0B
Q1 24
$1.8B
$2.0B
Total Assets
EE
EE
RGEN
RGEN
Q4 25
$4.1B
$2.9B
Q3 25
$4.1B
$2.9B
Q2 25
$4.0B
$2.9B
Q1 25
$2.9B
$2.9B
Q4 24
$2.9B
$2.8B
Q3 24
$2.9B
$2.8B
Q2 24
$2.9B
$2.9B
Q1 24
$2.9B
$2.8B
Debt / Equity
EE
EE
RGEN
RGEN
Q4 25
0.42×
0.26×
Q3 25
0.43×
0.26×
Q2 25
0.44×
Q1 25
0.17×
Q4 24
0.18×
0.27×
Q3 24
0.18×
Q2 24
0.19×
Q1 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EE
EE
RGEN
RGEN
Operating Cash FlowLast quarter
$104.4M
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EE
EE
RGEN
RGEN
Q4 25
$104.4M
$25.7M
Q3 25
$114.9M
$48.1M
Q2 25
$87.1M
$28.6M
Q1 25
$154.8M
$15.0M
Q4 24
$49.6M
$39.2M
Q3 24
$39.8M
$49.3M
Q2 24
$90.4M
$42.2M
Q1 24
$64.7M
$44.7M
Free Cash Flow
EE
EE
RGEN
RGEN
Q4 25
$17.6M
Q3 25
$43.4M
Q2 25
$21.5M
Q1 25
$11.4M
Q4 24
$33.6M
Q3 24
$42.3M
Q2 24
$37.4M
Q1 24
$36.4M
FCF Margin
EE
EE
RGEN
RGEN
Q4 25
8.9%
Q3 25
23.0%
Q2 25
11.8%
Q1 25
6.8%
Q4 24
19.3%
Q3 24
27.3%
Q2 24
24.3%
Q1 24
24.0%
Capex Intensity
EE
EE
RGEN
RGEN
Q4 25
4.1%
Q3 25
2.5%
Q2 25
3.9%
Q1 25
2.1%
Q4 24
3.2%
Q3 24
4.5%
Q2 24
3.1%
Q1 24
5.5%
Cash Conversion
EE
EE
RGEN
RGEN
Q4 25
1.93×
Q3 25
3.23×
Q2 25
1.92×
Q1 25
2.57×
Q4 24
Q3 24
Q2 24
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EE
EE

Other$179.4M57%
Revenue From Leases$138.1M43%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons